PeptideDB

Garvicin KS, GakA

CAS: 2098351-24-5 F: C161H259N43O39S W: 3453.11

Garvicin KS, GakA is a peptide at sizes of 34 amino acids to form bacteriocin garvicin KS (GarKS), with other 2 peptides
Sales Email:peptidedb@qq.com

This product is for research use only, not for human use. We do not sell to patients.

Bioactivity Garvicin KS, GakA is a peptide at sizes of 34 amino acids to form bacteriocin garvicin KS (GarKS), with other 2 peptides, GakB, and GakC. Garvicin KS, GakA inhibits fibroblast viability and proliferation. Garvicin KS, GakA with GakB, is a potent combination with good peptide stability, antimicrobial efficacy, and fibroblast viability/proliferation effects. Garvicin KS peptides inhibit MSSA with MIC values in the order GakB >GakC >GakA[1].
Name Garvicin KS, GakA
CAS 2098351-24-5
Sequence Met-Gly-Ala-Ile-Ile-Lys-Ala-Gly-Ala-Lys-Ile-Val-Gly-Lys-Gly-Val-Leu-Gly-Gly-Gly-Ala-Ser-Trp-Leu-Gly-Trp-Asn-Val-Gly-Glu-Lys-Ile-Trp-Lys
Shortening MGAIIKAGAKIVGKGVLGGGASWLGWNVGEKIWK
Formula C161H259N43O39S
Molar Mass 3453.11
Transport Room temperature in continental US; may vary elsewhere.
Storage

Please store the product under the recommended conditions in the Certificate of Analysis.

Reference [1]. Thapa RK, et al. Preformulation studies on novel garvicin KS peptides for topical applications. Eur J Pharm Sci. 2020 Aug 1;151:105333.